1. Home
  2. SYRE vs TCBK Comparison

SYRE vs TCBK Comparison

Compare SYRE & TCBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • TCBK
  • Stock Information
  • Founded
  • SYRE 2013
  • TCBK 1975
  • Country
  • SYRE United States
  • TCBK United States
  • Employees
  • SYRE 60
  • TCBK N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • TCBK Major Banks
  • Sector
  • SYRE Health Care
  • TCBK Finance
  • Exchange
  • SYRE Nasdaq
  • TCBK Nasdaq
  • Market Cap
  • SYRE 1.3B
  • TCBK 1.5B
  • IPO Year
  • SYRE 2016
  • TCBK N/A
  • Fundamental
  • Price
  • SYRE $21.29
  • TCBK $44.05
  • Analyst Decision
  • SYRE Strong Buy
  • TCBK Hold
  • Analyst Count
  • SYRE 8
  • TCBK 5
  • Target Price
  • SYRE $51.50
  • TCBK $50.75
  • AVG Volume (30 Days)
  • SYRE 550.7K
  • TCBK 82.9K
  • Earning Date
  • SYRE 03-03-2025
  • TCBK 01-23-2025
  • Dividend Yield
  • SYRE N/A
  • TCBK 2.96%
  • EPS Growth
  • SYRE N/A
  • TCBK N/A
  • EPS
  • SYRE N/A
  • TCBK 3.46
  • Revenue
  • SYRE N/A
  • TCBK $389,190,000.00
  • Revenue This Year
  • SYRE $168.62
  • TCBK N/A
  • Revenue Next Year
  • SYRE $47.61
  • TCBK $5.63
  • P/E Ratio
  • SYRE N/A
  • TCBK $12.88
  • Revenue Growth
  • SYRE N/A
  • TCBK N/A
  • 52 Week Low
  • SYRE $20.13
  • TCBK $31.73
  • 52 Week High
  • SYRE $47.97
  • TCBK $51.06
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 40.66
  • TCBK 48.02
  • Support Level
  • SYRE $21.61
  • TCBK $43.90
  • Resistance Level
  • SYRE $23.04
  • TCBK $45.07
  • Average True Range (ATR)
  • SYRE 1.43
  • TCBK 1.05
  • MACD
  • SYRE -0.03
  • TCBK 0.03
  • Stochastic Oscillator
  • SYRE 22.03
  • TCBK 42.68

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

Share on Social Networks: